NSE: JYOTHYLAB | BSE: 532926

Expensive Underperformer

Download real time

338.75 -1.05 (-0.31%)

43.15% Fall from 52W High

444.5K NSE+BSE Volume

NSE 21 May, 2025 3:31 PM (IST)

12,439.4

Market Cap

Below industry Median

0.5

Beta 1Year

Very Low volatility

Jyothy Labs Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for JYOTHYLAB, BSE:532926 Jyothy Labs Ltd.

Jyothy Labs Ltd.

18 Jan 2018

338.75

-0.31%

Jyothy Laboratories - 3QFY18 Result Update

Buy: Jyothy Labs Ltd.

Reliance Securities

Backed by 11.5% volume growth, Jyothy Laboratories (JYL) has reported revenues, EBITDA and net profit of Rs4.3bn, 693mn and 329mn, respectively in 3QFY18. Adjusted for GST-related accounting impact, revenues for the quarter rose by 15.9% YoY. We expect JYL to report revenue and adjusted earnings CAGR of 9.8% and 21%, respectively through FY17-20E. We remain positive on the stock considering strong earnings growth and reasonable valuations at 27.5x FY20E earnings (20% discount to sector multiples ex-ITC). Hence, we maintain our BUY recommendation on the...

Jyothy Labs Ltd. is trading below all available SMAs

Jyothy Labs Ltd.

17 Jan 2018

338.75

-0.31%

Jyothy Laboratories: Mixed performance; Growth outlook maintained

Neutral: Jyothy Labs Ltd.

Motilal Oswal

Consol. net sales grew 12.3% YoY to INR4.3b. Reported power brand sales grew just 9.3% YoY. EBITDA rose 36.8% YoY to INR693m (est. of INR610m). Adj. PAT after non-controlling interest (NCI) grew 61.5% YoY to INR347m (est. of INR347m). Fabric care, Dish washing and Personal care grew 9%, 12.4% and 30.9%, respectively, while Household Insecticides fell 17.1% YoY. Changes to the model have not resulted in material changes in FY18/FY19/FY20E EPS. Pace of earnings growth (for FY17-20E) appears moderate for a company that is much smaller in terms of size compared to mid-cap peers. RoE is also at a discount to peers at ~18% and 21.7% for FY19E and FY20E, respectively. Given these worries, valuation of 21.8x FY19E EV/ EBITDA and 33.8x FY19E EPS does not offer scope for a significant upside. Targeting 20x Dec'19E EV/ EBITDA (20% discount to staples peers' average),we get a TP of INR380 (INR375 earlier). Maintain Neutral.

Jyothy Labs Ltd. has an average target of 461.00 from 5 brokers.

Jyothy Labs Ltd.

10 Nov 2017

338.75

-0.31%

Jyothy Laboratories Ltd. - Result Update - 10 November 2017

Hold: Jyothy Labs Ltd.

Way2Wealth

1. The company reported a GST comparable topline growth of 9.6% to `430crs. The growth was driven by the Dishwashing and Personal Care categories. Volume grew by 3.5% YoY. Power brands GST comparable growth was at 11.4%....

Jyothy Labs Ltd. has an average target of 461.00 from 5 brokers.

Jyothy Labs Ltd.

10 Nov 2017

338.75

-0.31%

Result Update:Jyothy Lab.

Hold: Jyothy Labs Ltd.

Axis Direct

Jyothy's stock has corrected ~14% today, as Henkel did not exercise the option to buy 26% stake in Jyothy a major trigger for Jyothy. Stock has de-rated from 1-year average forward PE of 35x to 30x now, which is very much on expected lines.

Number of FII/FPI investors decreased from 224 to 215 in Mar 2025 qtr

Jyothy Labs Ltd.

08 Nov 2017

338.75

-0.31%

Jyothy Laboratories

Hold: Jyothy Labs Ltd.

ICICI Securities Limited

JLL's (standalone) revenue came in at | 419.3 crore, 9.5% YoY growth (GST comparable), against our estimate of | 406.9 crore. Revenue growth was supported by some revival in rural consumer demand...

Motilal Oswal decreased Neutral price target of Jyothy Labs Ltd. to 375.0 on 12 May, 2025.

Jyothy Labs Ltd.

07 Nov 2017

338.75

-0.31%

Jyothy Laboratories - 2QFY18 Result Update

Buy: Jyothy Labs Ltd.

Reliance Securities

Henkel Buyback Lapses; Overshadows Decent Operating Performance Jyothy Laboratories (JYL) has reported a decent set of results in 2QFY18. While its reported consolidated sales grew by 4.3% YoY to Rs4.3bn, comparable revenue growth post accounting for GST stood at 9.6% YoY. Volume grew by a modest 3.5% YoY during the quarter. Consolidated EBITDA increased by 11.3% YoY to Rs709mn with 100bps YoY improvement in EBITDA margins to...

Motilal Oswal decreased Neutral price target of Jyothy Labs Ltd. to 375.0 on 12 May, 2025.

Jyothy Labs Ltd.

07 Nov 2017

338.75

-0.31%

He nkel option agreement lapsed; operating performance below expectat

Neutral: Jyothy Labs Ltd.

Motilal Oswal

Henkel option agreement lapsed; operating performance below expectation Consol. net sales grew 4.3% YoY to INR4.3b. Reported power brand sales grew just 0.8% YoY. EBITDA rose 11.3% YoY to INR709m (est. of INR741m). Adj. PAT after non-controlling interest (NCI) grew 48.5% YoY to INR476m (est. of INR476m). Fabric care and Mosquito repellent fell 6.2% and 4.4% YoY, respectively. Dishwashing segment was flat and Personal care grew 38.9% YoY. Consol. gross margin contracted 90bp YoY to 48.1%. Other expenses declined sharply by 230bp YoY, while staff costs and A&P; rose 10bp and 40bp,...

Jyothy Labs Ltd. is trading below all available SMAs

Jyothy Labs Ltd.

29 Aug 2017

338.75

-0.31%

Analyst Meet Update - Jyothy Lab

Hold: Jyothy Labs Ltd.

Axis Direct

While restocking-led recovery is seen in Q2 (General Trade growth at 18% in July), Jyothy Laboratories (JYL) went on fixing issues at different channels of supply chain: (i) impact of wholesale disturbance by strategizing to reach affected centers via new sub-stockists

Jyothy Labs Ltd. has an average target of 461.00 from 5 brokers.

Jyothy Labs Ltd.

19 Aug 2017

338.75

-0.31%

Jyothy Laboratories Ltd: Degrowth in Volumes Due to Destocki... (Aug 19, 2017)

Hold: Jyothy Labs Ltd.

Karvy

Degrowth in Volumes Due to Destocking in Supply Chain; and Household Insecticides in Focus Going Forward:Jyothy Laboratories Ltd (JLL) has reported disappointing set of numbers in Q1FY18 due to destocking across distribution channels before the implementation of GST,Revenue from Operations of the company declined to Rs.3858 Mn during the quarter from Rs.4529 Mn during Q1FY17 registering YoY degrowth of 14.8%.General trade, which is contributing 79.0% of total Trade channel, is declined by 18.0% where wholesale is consisting 35.0% of total General Trade.

Jyothy Labs Ltd. is trading below all available SMAs

Is Jyothy Labs Ltd. worth buying?

280 Votes:

Buy 80.71%

Sell 11.43%

Hold 7.86%

RESEARCH REPORTS

Neutral SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf